Biomimetic Hydrogel‐Mediated Mechano‐Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery
Advanced Science · 2024
DOI: 10.1002/advs.202308734 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Yunze Dong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, P. R. China. Hauptthemen laut MEDLINE: Hydrogels, Neoplasm Recurrence, Local, Disease Models, Animal, Carcinoma, Renal Cell. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Hongkou District Clinical Medicine Talent Training Program, Shanghai Fourth People's Hospital talent promotion program.
Abstract (Originalsprache)
The unique physical tumor microenvironment (TME) and aberrant immune metabolic status are two obstacles that must be overcome in cancer immunotherapy to improve clinical outcomes. Here, an in situ mechano‐immunometabolic therapy involving the injection of a biomimetic hydrogel is presented with sequential release of the anti‐fibrotic agent pirfenidone, which softens the stiff extracellular matrix, and small interfering RNA IDO1, which disrupts kynurenine‐mediated immunosuppressive metabolic pathways, together with the multi‐kinase inhibitor sorafenib, which induces immunogenic cell death. This combination synergistically augmented tumor immunogenicity and induced anti‐tumor immunity. In mouse models of clear cell renal cell carcinoma, a single‐dose peritumoral injection of a biomimetic hydrogel facilitated the perioperative TME toward a more immunostimulatory landscape, which prevented tumor relapse post‐surgery and prolonged mouse survival. Additionally, the systemic anti‐tumor surveillance effect induced by local treatment decreased lung metastasis by inhibiting epithelial‐mesenchymal transition conversion. The versatile localized mechano‐immunometabolic therapy can serve as a universal strategy for conferring efficient tumoricidal immunity in “cold” tumor postoperative interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, P. R. China.
- Department of Urology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, P. R. China.
- Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of…
- Department of Ultrasound, Institute of Ultrasound in Medicine and Engineering, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China.
ORCID-Profile: Yunfei Xu
Förderung
- National Natural Science Foundation of China
- Shanghai Hongkou District Clinical Medicine Talent Training Program
- Shanghai Fourth People's Hospital talent promotion program
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Dong, Y., Luo, J., Pei, M., Liu, S., Gao, Y., Zhou, H., Nueraihemaiti, Y., Zhan, X., Xie, T., Yao, X., Guan, X., & Xu, Y. (2024). Biomimetic Hydrogel‐Mediated Mechano‐Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery. Advanced Science. https://doi.org/10.1002/advs.202308734
Vancouver
Dong Y, Luo J, Pei M, Liu S, Gao Y, Zhou H, et al. Biomimetic Hydrogel‐Mediated Mechano‐Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery. Advanced Science. 2024. doi:10.1002/advs.202308734
BibTeX
@article{Dong2024,
author = {Dong, Yunze and Luo, Jun and Pei, Mingliang and Liu, Shuai and Gao, Yuchen and Zhou, Hongmin and Nueraihemaiti, Yimingniyizi and Zhan, Xiangcheng and Xie, Tiancheng and Yao, Xudong and Guan, Xin and Xu, Yunfei},
title = {Biomimetic Hydrogel‐Mediated Mechano‐Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202308734}
}
EUVIMED